Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,425.00p
   
  • Change Today:
      15.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,920.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 112,706
  • Market Cap: 3,567.88m
  • RiskGrade: 128
  • Beta: 0.01

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
30-Jun-17 Interim 00.00      
  Final 13.30p 25-Nov-11 09-Nov-11 11-Nov-11
30-Jun-18 Interim 8.10p 04-Apr-18 08-Mar-18 09-Mar-18
  Final 17.90p 30-Nov-18 15-Nov-18 16-Nov-18
30-Jun-19 Interim 8.90p 04-Apr-19 07-Mar-19 08-Mar-19
  Final 18.80p 29-Nov-19 07-Nov-19 08-Nov-19
30-Jun-20 Interim 9.40p 02-Apr-20 05-Mar-20 06-Mar-20
  Final 19.70p 11-Dec-20 19-Nov-20 20-Nov-20
30-Jun-21 Interim 10.30p 01-Apr-21 04-Mar-21 05-Mar-21
  Final 21.70p 10-Dec-21 18-Nov-21 19-Nov-21

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 5,425.00p
Change Today 15.00p
% Change 0.28 %
52 Week High 6,070.00
52 Week Low 3,920.00
Volume 112,706
Shares Issued 65.77m
Market Cap 3,567.88m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
57.58% above the market average57.58% above the market average57.58% above the market average57.58% above the market average57.58% above the market average
52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average
Income
64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
83.43% above the market average83.43% above the market average83.43% above the market average83.43% above the market average83.43% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 3
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 15-Oct-2021

Time Volume / Share Price
16:35 79,759 @ 5,425.00p
16:29 1,000 @ 5,450.00p
16:29 16 @ 5,445.00p
16:29 4 @ 5,445.00p
16:29 136 @ 5,445.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page